| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-10 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
2e-09 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-08 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |